At its 174th session in November 2022, the European Pharmacopoeia (Ph. Eur.) Commission decided to create a new Working Party on High Throughput Sequencing (HTS), in charge of elaborating a general chapter on HTS for the detection of viral extraneous agents. Also known as NGS, this advanced technology has broad virus detection capability and the new general chapter should facilitate its use as a new analytical tool to ensure the viral safety of biological medicines.
Specialists with expertise in HTS for the detection of extraneous agents in biologicals and in the development and validation of analytical procedures based on HTS (e.g. from licensing authorities, official medicines control laboratories or industry) are invited to apply to join the new Working Party on this important journey to develop a quality standard for HTS.
More information on how to apply can be found on the web page “Join the Network!”.